Department of Clinical Pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, 14132, Iraq.
Biochemistry Department, Faculty of Pharmacy, Tanta University, Tanta, 31527, Egypt.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan;397(1):33-40. doi: 10.1007/s00210-023-02656-6. Epub 2023 Aug 9.
Parkinson's disease (PD) is a neurodegenerative brain disease (NBD) developed due to dopaminergic neuron loss in the substantia nigra (SN). Vitamin D (VD), VD receptor (VDR), and VD metabolites are highly expressed in the human brain and play a critical role in maintaining different brain functions. VDRs are highly expressed in the SN that regulates the activity of dopaminergic neurons and synaptic plasticity. VD exerts protective and therapeutic effects against the development of PD by modulating dopaminergic neurons of SN. VD reduces oxidative stress and neuroinflammation in PD because of its anti-inflammatory and antioxidant activities. Different studies revealed the protective effect of VD in the management of PD. However, the potential therapeutic effect of VD in well-established PD remains controversial. Therefore, this review aims to elucidate VD's preventive and therapeutic roles in PD. In conclusion, VD deficiency is associated with increased PD risk, but VD supplementation in well-established PD plays little role.
帕金森病(PD)是一种神经退行性脑疾病(NBD),由于黑质(SN)中的多巴胺能神经元丧失而发展。维生素 D(VD)、VD 受体(VDR)和 VD 代谢物在人脑中有很高的表达水平,对维持不同的脑功能起着关键作用。VDR 在 SN 中高表达,调节多巴胺能神经元的活性和突触可塑性。VD 通过调节 SN 中的多巴胺能神经元对 PD 的发生发展发挥保护和治疗作用。VD 通过抗炎和抗氧化作用减少 PD 中的氧化应激和神经炎症。不同的研究揭示了 VD 在 PD 管理中的保护作用。然而,VD 在已建立的 PD 中的潜在治疗效果仍存在争议。因此,本综述旨在阐明 VD 在 PD 中的预防和治疗作用。总之,VD 缺乏与 PD 风险增加有关,但在已建立的 PD 中补充 VD 作用不大。